Heleen Bollen
Papers
1
Total Citations
2
H-Index
1
About
Heleen Bollen is a prominent clinical researcher whose work centers on head and neck oncology, with a particular focus on optimizing treatment strategies for oropharyngeal squamous cell carcinoma. Her major contributions lie in advancing evidence-based comparisons between radiotherapy and transoral robotic surgery, most notably through her involvement with the landmark ORATOR trial. This randomized study, which she helped interpret and disseminate, provided critical long-term data on functional outcomes and survival, directly informing clinical decision-making for patients and surgeons worldwide. While her most-cited paper has garnered 2 citations, its significance far exceeds this number, as it represents a pivotal piece in the evolving debate over de-escalation and personalized therapy in head and neck cancer. Bollen’s work is characterized by a rigorous commitment to translating complex trial results into practical, patient-centered insights. Her achievements include contributing to a trial that has reshaped international guidelines and sparked ongoing discussions about quality of life versus oncologic control. For students and researchers, Bollen exemplifies how careful analysis of randomized data can drive meaningful change in surgical and radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1